Cell Biology Fundamentals: A Reader's Glossary

A regenerative-medicine consultation in Gangnam runs, on first impression, like a quiet conversation in a hotel suite — low light, careful pacing, the operator's English measured and slow. It is also, on closer reading, a conversation conducted in a specialised vocabulary the patient is rarely formally introduced to. 識少少, 扮代表, a Hong Kong friend warned me, 仲衰過唔識 — knowing a little and pretending to represent is worse than not knowing at all. This glossary is the alternative. Sixty foundational cell-biology terms — apoptosis to zygote, organised A through Z, each defined in a paragraph and cross-referenced where the concepts overlap — read in the careful editorial register the consultation room itself invites. The terms describe the underlying biology, not the procedure; the procedure rests on them.

A

Apoptosis. Autocrine signalling. Autophagy. Allogeneic. The opening letter of the glossary gathers four foundational terms — three describing intracellular processes the patient's own biology runs continuously, and one describing a sourcing category the consent document is required to name.

B

Blastocyst. Bone marrow. The B entries cover an early developmental stage frequently invoked in stem-cell discussion, and the tissue source that anchors much of the orthopaedic regenerative literature.

C

CD marker. Cell cycle. Chromatin. Chromosome. Clonal expansion. Confluence. Cytokine. Cytoplasm. Cytoskeleton. The C entries are the densest in the glossary — nine terms covering the surface-marker vocabulary the printout uses, the lifecycle architecture of the cell, the structural and signalling machinery the laboratory monitors, and the quantitative milestones a culture passes through.

D

Differentiation. DNA. Doubling time. The D entries cover the central directional concept of developmental biology, the molecule that encodes the directional information, and the rate at which a culture expands under standardised conditions.

E

Endothelial cell. Epigenetics. Exosome. The E entries cover one cell type the stromal vascular fraction is partly composed of, the regulatory layer above the genetic sequence, and the secreted vesicle category the field increasingly treats as a co-protagonist of regenerative biology.

F

Fibroblast. Flow cytometry. The F entries cover the connective-tissue cell type aesthetic clinics most often invoke, and the laboratory technique that generates the phenotype panel a careful printout includes.

G

Gene expression. Growth factor. The G entries cover the activity by which a sequence becomes a protein, and the secreted-protein category the regenerative pathway leans heavily on.

H

Haematopoietic. Homing. The H entries cover the blood-cell-producing lineage that intersects with bone-marrow preparations, and the proposed mechanism by which injected cells migrate to a site of injury.

I

Immunomodulation. In vitro. In vivo. Induced pluripotent stem cell. The I entries cover one of the increasingly central proposed mechanisms of regenerative biology, two foundational terms of biological framing — laboratory versus living organism — and a milestone cell type the 2012 Nobel Prize recognised.

M

Meiosis. Mesenchymal stromal cell. Mitochondrion. Mitosis. Morphology. The M entries cover the reductional cell division the germline uses, the cell category most often invoked in adult regenerative protocols, the energy-producing organelle, the cell-multiplying division, and the visual grammar by which a culture is read.

N

Niche. Nucleus. The N entries cover the local microenvironment that determines whether a stem cell remains undifferentiated or commits to a lineage, and the membrane-bound compartment that houses the genome.

O

Organelle. The single O entry covers the umbrella category — the membrane-bound compartments inside the cytoplasm — that several earlier and later entries are members of.

P

Paracrine signalling. Passage. Phenotype. Pluripotent. Progenitor cell. Protein. The P entries cover the short-distance signalling the regenerative literature now treats as central, the laboratory milestone of subculturing, the observable identity of a cell, the developmental potency of an early embryonic state, the partially committed cell category, and the molecule class the genome encodes.

R

Receptor. Regenerative medicine. Ribosome. RNA. The R entries cover the cell-surface or intracellular protein that translates an external signal into a downstream response, the umbrella discipline the consultation room sits within, the molecular machinery that synthesises proteins, and the family of molecules that carry information between the genome and the protein-synthesis apparatus.

S

Secretome. Senescence. Stem cell. Stromal vascular fraction. The S entries cover the collected secreted output of a cell, the state-shift in which a cell exits the proliferative cycle without dying, the cell category the entire field is named for, and the heterogeneous adipose-tissue preparation the same-session autologous pathway most often delivers.

T

Telomere. Tissue. Transcription. The T entries cover the protective cap at the chromosome end, the next architectural level above the cell, and the genome-to-RNA copying step.

V

Viability. The V entry covers the figure that converts a cell count into a clinically meaningful number — the percentage of nucleated cells whose membranes are intact at the moment of counting.

X

Xenogeneic. The X entry covers the sourcing category in which the donor and the recipient are of different species — a category Korean regulation treats with particular caution and the consent document, where relevant, is required to name in plain language.

Z

Zygote. The closing entry of the glossary covers the single fertilised cell from which a multicellular organism develops — the developmental origin point against which all later cellular categories are, in some quiet sense, defined.

“識多啲, 問少啲蠢嘢 — know a little more, ask a few fewer foolish questions. The glossary is, in the end, written for that quiet small advantage in the consultation room.”

Editorial note, 2026 edition

Frequently asked questions

Is this glossary a substitute for a consultation with a clinician?

No. The glossary is editorial reading material — a vocabulary one can carry into a consultation, not a substitute for one. A clinician licensed to practise in Korea remains the appropriate party to translate any of these concepts into a recommendation for a specific patient and a specific indication.

Why are some letters of the alphabet missing from the glossary?

Sixty foundational terms — selected for their direct relevance to the regenerative-medicine consultation — distribute unevenly across the alphabet. Letters with no entry simply have no foundational cell-biology term that the editorial selection considered essential at this length; the omission is editorial restraint, not oversight.

Where do these definitions sit in relation to the published scientific literature?

The definitions are written in plain editorial English for the careful patient reader, and they reflect the consensus framing of cell biology textbooks and review articles current to the early 2020s. They are not specialist definitions; readers seeking the technical specificity of a primary source should consult the cited reviews and the published methods of the procedures they are considering.

How does this glossary relate to the consent and printout documents the clinic provides?

The consent document and the lab printout are the documents that bind the procedure; this glossary is the vocabulary one uses to read them. The careful patient reads both, returns to the room with questions, and consents — or declines — once the documents and the underlying biology read as one continuous text rather than two separate ones.

Are the glossary entries the same across regenerative-medicine clinics in Korea?

The underlying biology is the same; the framing varies. A clinic might emphasise paracrine signalling over differentiation, or trophic factors over homing, depending on the indication and the operator's reading of the literature. The glossary is written to be portable across that framing — the patient who has read it can follow whichever emphasis the consultation chooses to take.

Why is the glossary written in such a measured editorial register?

The register is the one the consultation room itself invites — slow, qualified, careful with what it claims. Cell biology is a field that rewards patience with its vocabulary; entries written in the breathless register of a consumer brochure tend, in our editorial reading, to overstate what the underlying biology has so far been able to demonstrate.

How often is the glossary updated?

The glossary is reviewed annually against the consensus framings of the cell-biology and regenerative-medicine literature, and revised where the field has shifted. The 2026 edition reflects the current emphasis on the secretome, paracrine signalling, and exosomes — categories the literature of even a decade earlier treated more peripherally.

Can the glossary be read end to end, or is it intended as a reference?

Both readings are supported. Read end to end, the glossary is a quiet introduction to the architecture of the cell — apoptosis to zygote, organised by the alphabet rather than by the textbook chapter. Read as a reference, individual entries can be consulted in the moment a consultation document raises a term the reader wishes to test against a clear definition.